N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease

European Heart Journal

Volumn 35, Issue 11, 2014, Pages 708-715

  Kampman, Marlies A M ^a,b   Balci, Ali ^a   Van Veldhuisen, Dirk J ^a   Van Dijk, Arie P J ^c   Roos Hesselink, Jolien W ^d   Sollie Szarynska, Krystyna M ^a   Ludwig Ruitenberg, Marieke ^a   Van Melle, Joost P ^a   Mulder, Barbara J M ^e   Pieper, Petronella G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Congenital heart disease; Natriuretic peptides; Pregnancy; Right ventricular function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AORTA COARCTATION; AORTA DISSECTION; AORTA SUBVALVULAR STENOSIS; AORTA VALVE STENOSIS; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; BICUSPID AORTIC VALVE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONCEPTION; CONGENITAL HEART DISEASE; CYANOTIC HEART DISEASE; EBSTEIN ANOMALY; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEART ATRIUM SEPTUM DEFECT; HEART EJECTION FRACTION; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VALVE REPLACEMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INVASIVE PROCEDURE; LOEYS DIETZ SYNDROME; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MARFAN SYNDROME; MECHANICAL HEART VALVE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PACEMAKER; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE THROMBOSIS; PULMONARY VALVE STENOSIS; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SUBPULMONARY VENTRICULAR DYSFUNCTION; THIRD TRIMESTER PREGNANCY;

CONGENITAL HEART DISEASE; NATRIURETIC PEPTIDES; PREGNANCY; RIGHT VENTRICULAR FUNCTION;

ADULT; BIOLOGICAL MARKERS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES;

EID: 84899004917     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht526     Document Type: Article

References (36)

1. DrenthenW, Pieper PG, Roos-HesselinkJW, van LottumWA, Voors AA, Mulder BJ, van Dijk AP, Vliegen HW, Yap SC, Moons P, Ebels T, van Veldhuisen DJ, ZAHARA Investigators. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol 2007;49:2303-2311. (Pubitemid 46891708)
2. Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, Vliegen HW, van Dijk AP, Voors AA, Yap SC, van Veldhuisen DJ, Pieper PG, ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124-2132
3. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation 2006; 113:517-524
4. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S, Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-521
5. JastrowN, Meyer P, Khairy P, Mercier LA, Dore A, Marcotte F, Leduc L. Prediction of complications in pregnantwomen with cardiac diseases referred to a tertiary center. Int J Cardiol 2011;151:209-213
6. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006;92:1520-1525. (Pubitemid 44578860)
7. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, ESC Committee for Practice Guidelines, Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-3197
8. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-Terminal pro-B-Type natriuretic peptide and long-Term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-675. (Pubitemid 40239214)
9. Linssen GC, Bakker SJ, Voors AA, Gansevoort RT, Hillege HL, de Jong PE, van Veldhuisen DJ, Gans RO, de Zeeuw D. N-Terminal pro-B-Type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J 2010;31:120-127
10. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K. N-Terminal pro-B-Type natriuretic peptide and long-Term mortality in acute coronary syndromes. Circulation 2002;106:2913-2918. (Pubitemid 35424741)
11. Kirk V, Bay M, Parner J, Krogsgaard K, Herzog TM, Boesgaard S, Hassager C, NielsenOW, Aldershvile J, Nielsen H. N-Terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs.: Reduced systolic function: Data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail 2004;6:335-341. (Pubitemid 38253054)
12. van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL. B-Type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 2013;61:1498-1506
13. Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD, Sermer M, Colman JM, Silversides CK. B-Type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 2010;56:1247-1253
14. Balci A, Sollie KM, Mulder BJ, de Laat MW, Roos-Hesselink JW, van Dijk AP, Wajon EM, Vliegen HW, Drenthen W, Hillege HL, Aarnoudse JG, van Veldhuisen DJ, Pieper PG. Associations between cardiovascular parameters and uteroplacental Doppler (blood) flowpatterns during pregnancy inwomenwith congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. Am Heart J 2011;161:269-275.e1
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, RomanMJ, Seward J, Shanewise JS, Solomon SD, SpencerKT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. (Pubitemid 41821197)
16. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M, American Society of Echocardiography, European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22: 1-23; quiz 101-2
17. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-133
18. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713; quiz 786-788
19. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442
20. StanglV, Schad J,GossingG,Borges A, BaumannG, StanglK.Maternalheart disease and pregnancy outcome: A single-centre experience. Eur J Heart Fail 2008;10:855-860
21. Roos-Hesselink JW, Ruys TP, Stein JI, Thilen U,Webb GD, Niwa K, Kaemmerer H, Baumgartner H, BudtsW, Maggioni AP, Tavazzi L, Taha N, Johnson MR, Hall R, on behalf of the ROPAC Investigators. Outcome of pregnancy in patients with structural or ischaemic heart disease: Results of a registry of the European Society of Cardiology. Eur Heart J 2013;34:657-665
22. Siu SC, Colman JM, Sorensen S, Smallhorn JF, Farine D, Amankwah KS, Spears JC, Sermer M. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-2184. (Pubitemid 34517162)
23. Pieper PG, Balci A, Van Dijk AP. Pregnancy in women with prosthetic heart valves. Neth Heart J 2008;16:406-411
24. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG 2000;107:245-253. (Pubitemid 30081591)
25. Elkayam U, Bitar F. Valvular heart disease and pregnancy: Part II: Prosthetic valves. J Am Coll Cardiol 2005;46:403-410. (Pubitemid 41040278)
26. Greutmann M, Von Klemperer K, Brooks R, Peebles D, O'Brien P,Walker F. Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J 2010;31:1764-1770
27. Koestenberger M, Nagel B,Avian A, RavekesW, Sorantin E, Cvirn G, Beran E, HalbV, Gamillscheg A. Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: Tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging data. Congenit Heart Dis 2012;7:250-258
28. Koestenberger M, Nagel B, RavekesW, Everett AD, StuegerHP, Heinzl B, Sorantin E, Cvirn G, Fritsch P, Gamillscheg A. Systolic right ventricular function in pediatric and adolescent patients with tetralogy of Fallot: Echocardiography versus magnetic resonance imaging. J Am Soc Echocardiogr 2011;24:45-52
29. Fang F, HeneinMY, Yu CM, LiW, Kaya MG, Coats AJ, Lam YY. Right ventricular longaxis response to different chronic loading conditions: Its relevance to clinical symptoms. Int J Cardiol 2013;167:378-382
30. Drenthen W, Pieper PG, Ploeg M, Voors AA, Roos-Hesselink JW, Mulder BJ, Vliegen HW, Sollie KM, Ebels T, van Veldhuisen DJ, ZAHARA Investigators. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 2005;26:2588-2595. (Pubitemid 41677312)
31. Eindhoven JA, van den Bosch AE, Boersma E, Roos-Hesselink JW. The usefulness of brain natriuretic peptide in simple congenital heart disease - A systematic review. Cardiol Young 2013;23:315-324
32. Eindhoven JA, van den Bosch AE, Jansen PR, BoersmaE, Roos-HesselinkJW. Theusefulness of brain natriuretic peptide in complex congenital heart disease: A systematic review. J Am Coll Cardiol 2012;60:2140-2149
33. Giannakoulas G, Dimopoulos K, Bolger AP, Tay EL, Inuzuka R, Bedard E, Davos C, Swan L, Gatzoulis MA. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol 2010;105:869-873
34. Ishii H, Harada K, Toyono M, Tamura M, Takada G. Usefulness of exercise-induced changes in plasma levels of brain natriuretic peptide in predicting right ventricular contractile reserve after repair of tetralogy of Fallot. Am J Cardiol 2005;95: 1338-1343. (Pubitemid 40719866)
35. Lemmer J, Heise G, Rentzsch A, Boettler P, Kuehne T, Dubowy KO, Peters B, Lemmer B, Hager A, Stiller B, German Competence Network for Congenital Heart Defects. Right ventricular function in grown-up patients after correction of congenital right heart disease. Clin Res Cardiol 2011;100:289-296
36. Eindhoven JA, van den Bosch AE, Ruys TP, Opic P, Cuypers JA, McGhie JS, Witsenburg M, Boersma E, Roos-Hesselink JW. N-Terminal proBrain natriuretic peptide and its relation with cardiac function in adult patients with congenital heart disease. J Am Coll Cardiol 2013;62:1203-1212